Literature DB >> 25191772

Features of sleep disturbances in multiple sclerosis patients.

Rytis Leonavicius1, Virginija Adomaitiene.   

Abstract

BACKGROUND: Sleep disturbances in multiple sclerosis (MS) have received little research attention despite the potential influence it may have on the impact of the disease. The aim of this study was to evaluate the prevalence of sleep disturbances in a Lithuanian community sample of individuals with the relapsing remitting multiple sclerosis (RRMS) and its relation with depression, anxiety, and health related quality of life (HRQoL). SUBJECTS AND METHODS: The examined group consisted of 137 RRMS outpatients. The following questionnaires were used: the original socio-demographic questionnaire, Medical Outcomes Study Sleep (MOSS) measure, Hospital Anxiety and Depression Scale (HADS), and HRQoL measure. The relationship of objective sleep disturbances was evaluated with multivariate linear regression, adjusted to socio-demographic and clinical data.
RESULTS: Sleep disturbances were present in 45.3 percent of patients. According to the HADS-D, depressive symptoms were present in 21.9 percent, according to the HADS-A, anxiety symptoms were present in 19.7 percent of study participants. Mean value of Physical and Mental component of HRQoL respectively constituted 40.4 and 44.5. We observed the relationship between sleep disturbances and gender, age, EDSS, prevalence of depression and anxiety, and Physical and Mental component of HRQoL.
CONCLUSIONS: Our research was limited by narrow number of study participants and could be accepted only as preliminary study. The study investigated only RRMS patients, therefore investigation of other clinical forms of MS could provide more exhaustive data related with sleep disturbances. The investigation included only outpatients group, therefore research of inpatients could provide more comprehensive data. Sleep disturbances in our study were common in RRMS, and they related with female gender, older age, higher disability status, prevalence of depression and anxiety, and worse HRQoL. The treatable causes of sleep disturbances in RRMS should be identified and cured. However, further research are requested to confirm these findings.

Entities:  

Mesh:

Year:  2014        PMID: 25191772

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  11 in total

1.  Sleep and oligodendrocyte functions.

Authors:  Michele Bellesi
Journal:  Curr Sleep Med Rep       Date:  2015-03-01

2.  Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot randomized controlled trial.

Authors:  Catherine F Siengsukon; Mohammed Alshehri; Cierra Williams; Michelle Drerup; Sharon Lynch
Journal:  Mult Scler Relat Disord       Date:  2020-01-23       Impact factor: 4.339

Review 3.  Sleep disorders in multiple sclerosis. Review.

Authors:  Christian Veauthier
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

4.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

5.  The Neurological Sleep Index: A suite of new sleep scales for multiple sclerosis.

Authors:  R J Mills; A Tennant; C A Young
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-04-07

6.  Surveying sleep quality and fatigue in multiple sclerosis patients at a multiple sclerosis center in Kermanshah, Iran, in 2017.

Authors:  Saba Karimi; Milad Jalilian; Alireza Abdi; Habibolah Khazaie; Pegah Ahmadi Sarbarzeh
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2020-05-11

7.  The Impact of Cognitive Behavioral Therapy for Insomnia on Sleep Log and Actigraphy Outcomes in People with Multiple Sclerosis: A Secondary Analysis.

Authors:  Cierra Williams-Cooke; Leslie LeSuer; Michelle Drerup; Catherine Siengsukon
Journal:  Nat Sci Sleep       Date:  2021-10-12

8.  Short Report: Impact of Sleep Disorders on Depression and Patient-Perceived Health-Related Quality of Life in Multiple Sclerosis.

Authors:  Emily K White; Amy B Sullivan; Michelle Drerup
Journal:  Int J MS Care       Date:  2019 Jan-Feb

9.  Feasibility and Treatment Effect of a Web-Based Cognitive Behavioral Therapy for Insomnia Program in Individuals with Multiple Sclerosis: A Pilot Randomized Controlled Trial.

Authors:  Catherine F Siengsukon; Eber Silveira Beck; Michelle Drerup
Journal:  Int J MS Care       Date:  2020-06-26

10.  Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.

Authors:  Khadijeh Mohammadi; Parvin Rahnama; Ali Montazeri
Journal:  Ann Gen Psychiatry       Date:  2015-09-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.